ZOTEPINE IN THE TREATMENT OF SCHIZOPHRENIC-PATIENTS WITH PREVAILINGLY NEGATIVE SYMPTOMS - A DOUBLE-BLIND TRIAL VS HALOPERIDOL

被引：80

作者：

BARNAS, C

STUPPACK, CH

MILLER, C

HARING, C

SPERNERUNTERWEGER, B

FLEISCHHACKER, WW

机构：

[1] Biological Psychiatry Research Unit, Department of Psychiatry, University of Innsbruck

来源：

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 1992年 / 7卷 / 01期

关键词：

D O I：

10.1097/00004850-199200710-00003

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Zotepine, a neuroleptic agent with additional 5-HT2 blocking properties, was compared with haloperidol in the treatment of schizophrenic patients with predominantly negative symptoms using a double-blind design. During the investigation period zotepine treated patients showed significant improvements in all rating instruments whereas haloperidol treated patients did not. Patients in the zotepine group developed fewer clinical side effects. The results of the presented study confirm the positive impressions gained in earlier open trials with zotepine.

引用

页码：23 / 27

页数：5

共 30 条

[11]

FLEISCHHACKER WW, 1989, PSYCHOPHARMACOL BULL, V25, P97

[12] DOUBLE-BLIND THERAPEUTIC EVALUATION OF FLUSPIRILENE COMPARED WITH FLUPHENAZINE DECANOATE IN CHRONIC-SCHIZOPHRENICS [J].

FRANGOS, H ;

ZISSIS, NP ;

LEONTOPOULOS, I ;

DIAMANTAS, N ;

TSITOURIDIS, S ;

GAVRIIL, I ;

TSOLIS, K .

ACTA PSYCHIATRICA SCANDINAVICA, 1978, 57 (05) :436-446

[13] PIMOZIDE VERSUS HALOPERIDOL IN ACUTE SCHIZOPHRENIA - A DOUBLE-BLIND CONTROLLED-STUDY [J].

HAAS, S ;

BECKMANN, H .

PHARMACOPSYCHIATRIA, 1982, 15 (02) :70-74

[14]

KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789

[15]

KANE J M, 1982, Psychopharmacology Bulletin, V18, P20

[16]

KANE J M, 1989, British Journal of Psychiatry, V155, P115

[17]

KEITH SJ, 1984, HOSP COMMUNITY PSYCH, V35, P802

[18]

KLIESER E, 1991, FORTSCHRITTE NEUROLO, V1, P14

[19]

KOLIVAKIS T, 1974, CURR THER RES CLIN E, V16, P998

[20]

LAPIERRE YD, 1978, AM J PSYCHIAT, V135, P956

← 1 2 3 →